Genomic rearrangements in MSH2, MLH1 or MSH6 are rare in HNPCC patients carrying point mutations

Cancer Letters

Volumn 248, Issue 1, 2007, Pages 89-95

  Pistorius, Steffen ^a   Görgens, Heike ^a   Plaschke, Jens ^a   Hoehl, Ruth ^a   Krüger, Stefan ^a   Engel, Christoph ^b   Saeger, Hans Detlev ^a   Schackert, Hans K ^a  

^a DRESDEN UNIVERSITY OF TECHNOLOGY   (Germany)

^b UNIVERSITY OF LEIPZIG   (Germany)

Author keywords

Exon deletions; HNPCC; Mismatch repair genes

Indexed keywords

DNA; PROTEIN MLH1; PROTEIN MSH2; PROTEIN MSH6;

ARTICLE; AUTOSOMAL DOMINANT DISORDER; CANCER GENETICS; COLORECTAL CANCER; CONTROLLED STUDY; DNA DETERMINATION; DNA PROBE; GENE; GENE AMPLIFICATION; GENE DELETION; GENE INSERTION; GENE REARRANGEMENT; GENE SEQUENCE; HUMAN; MAJOR CLINICAL STUDY; MICROSATELLITE INSTABILITY; MISMATCH REPAIR; MLH1 GENE; MLH3 GENE; MSH2 GENE; MSH6 GENE; NUCLEIC ACID BASE SUBSTITUTION; PENETRANCE; PMS2 GENE; POINT MUTATION; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN EXPRESSION;

EID: 33847308734     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.canlet.2006.06.002     Document Type: Article

References (41)

1. Bronner C.E., Baker S.M., Morrison P.T., Warren G., Smith L.G., Lescoe M.K., et al. Mutation in the DNA mismatch repair gene homologue hMLH1 is associated with hereditary non-polyposis colon cancer. Nature 368 (1994) 258-261
2. Kolodner R.D., Hall N.R., Lipford J., Kane M.F., Rao M.R., Morrison P., et al. Structure of the human MSH2 locus and analysis of two Muir-Torre kindreds for msh2 mutations. Genomics 24 (1994) 516-526
3. Kolodner R.D., Hall N.R., Lipford J., Kane M.F., Morrison P.T., Finan P.J., et al. Structure of the human MLH1 locus and analysis of a large hereditary nonpolyposis colorectal carcinoma kindred for mlh1 mutations. Cancer Res. 55 (1995) 242-248
4. Fishel R., Lescoe M.K., Rao M.R., Copeland N.G., Jenkins N.A., Garber J., et al. The human mutator gene homolog MSH2 and its association with hereditary nonpolyposis colon cancer. Cell 75 (1993) 1027-1038
5. Leach F.S., Nicolaides N.C., Papadopoulos N., Liu B., Jen J., Parsons R., et al. Mutations of a mutS homolog in hereditary nonpolyposis colorectal cancer. Cell 75 (1993) 1215-1225
6. Liu B., Parsons R., Papadopoulos N., Nicolaides N.C., Lynch H.T., Watson P., et al. Analysis of mismatch repair genes in hereditary non-polyposis colorectal cancer patients. Nat. Med. 2 (1996) 169-174
7. Miyaki M., Konishi M., Tanaka K., Kikuchi-Yanoshita R., Muraoka M., Yasuno M., et al. Germline mutation of MSH6 as the cause of hereditary nonpolyposis colorectal cancer. Nat. Genet. 17 (1997) 271-272
8. Papadopoulos N., Nicolaides N.C., Wei Y.F., Ruben S.M., Carter K.C., Rosen C.A., et al. Mutation of a mutL homolog in hereditary colon cancer. Science 263 (1994) 1625-1629
9. Nicolaides N.C., Papadopoulos N., Liu B., Wei Y.F., Carter K.C., Ruben S.M., et al. Mutations of two PMS homologues in hereditary nonpolyposis colon cancer. Nature 371 (1994) 75-80
10. Liu T., Yan H., Kuismanen S., Percesepe A., Bisgaard M.L., Pedroni M., et al. The role of hPMS1 and hPMS2 in predisposing to colorectal cancer. Cancer Res. 61 (2001) 7798-7802
11. Wu Y., Berends M.J., Sijmons R.H., Mensink R.G., Verlind E., Kooi K.A., et al. A role for MLH3 in hereditary nonpolyposis colorectal cancer. Nat. Genet. 29 (2001) 137-138
12. Peltomaki P., and Vasen H. Mutations associated with HNPCC predisposition - Update of ICG-HNPCC/INSiGHT mutation database. Dis. Markers 20 (2004) 269-276
13. Mangold E., Pagenstecher C., Friedl W., Mathiak M., Buettner R., Engel C., et al. Spectrum and frequencies of mutations in MSH2 and MLH1 identified in 1,721 German families suspected of hereditary nonpolyposis colorectal cancer. Int. J. Cancer 116 (2005) 692-702
14. Wijnen J., van der Klift H., Vasen H., Khan P.M., Menko F., Tops C., et al. MSH2 genomic deletions are a frequent cause of HNPCC. Nat. Genet. 20 (1998) 326-328
15. Charbonnier F., Raux G., Wang Q., Drouot N., Cordier F., Limacher J.M., et al. Detection of exon deletions and duplications of the mismatch repair genes in hereditary nonpolyposis colorectal cancer families using multiplex polymerase chain reaction of short fluorescent fragments. Cancer Res. 60 (2000) 2760-2763
16. Gille J.J., Hogervorst F.B., Pals G., Wijnen J.T., van Schooten R.J., Dommering C.J., et al. Genomic deletions of MSH2 and MLH1 in colorectal cancer families detected by a novel mutation detection approach. Br. J. Cancer 87 (2002) 892-897
17. Wagner A., Barrows A., Wijnen J.T., van der Klift H., Franken P.F., Verkuijlen P., et al. Molecular analysis of hereditary nonpolyposis colorectal cancer in the United States: high mutation detection rate among clinically selected families and characterization of an American founder genomic deletion of the MSH2 gene. Am. J. Hum. Genet. 72 (2003) 1088-1100
18. Nakagawa H., and Hampel H. A. de la Chapelle, Identification and characterization of genomic rearrangements of MSH2 and MLH1 in Lynch syndrome (HNPCC) by novel techniques. Hum. Mutat. 22 (2003) 258
19. Taylor C.F., Charlton R.S., Burn J., Sheridan E., and Taylor G.R. Genomic deletions in MSH2 or MLH1 are a frequent cause of hereditary non-polyposis colorectal cancer: identification of novel and recurrent deletions by MLPA. Hum. Mutat. 22 (2003) 428-433
20. Wang Y., Friedl W., Lamberti C., Jungck M., Mathiak M., Pagenstecher C., et al. Hereditary nonpolyposis colorectal cancer: frequent occurrence of large genomic deletions in MSH2 and MLH1 genes. Int. J. Cancer 103 (2003) 636-641
21. van der Klift H., Wijnen J., Wagner A., Verkuilen P., Tops C., Otway R., et al. Molecular characterization of the spectrum of genomic deletions in the mismatch repair genes MSH2, MLH1, MSH6, and PMS2 responsible for hereditary nonpolyposis colorectal cancer (HNPCC). Genes Chromosomes Cancer 44 (2005) 123-138
22. Grabowski M., Mueller-Koch Y., Grasbon-Frodl E., Koehler U., Keller G., Vogelsang H., et al. Deletions account for 17% of pathogenic germline alterations in MLH1 and MSH2 in hereditary nonpolyposis colorectal cancer (HNPCC) families. Genet. Test. 9 (2005) 138-146
23. Castellvi-Bel S., Castells A., Strunk M., Ferrandez A., Piazuelo E., Mila M., et al. Genomic rearrangements in MSH2 and MLH1 are rare mutational events in Spanish patients with hereditary nonpolyposis colorectal cancer. Cancer Lett. 225 (2005) 93-98
24. Wang Q., Lasset C., Desseigne F., Frappaz D., Bergeron C., Navarro C., et al. Neurofibromatosis and early onset of cancers in hMLH1-deficient children. Cancer Res. 59 (1999) 294-297
25. Ricciardone M.D., Ozcelik T., Cevher B., Ozdag H., Tuncer M., Gurgey A., et al. Human MLH1 deficiency predisposes to hematological malignancy and neurofibromatosis type 1. Cancer Res. 59 (1999) 290-293
26. De Rosa M., Fasano C., Panariello L., Scarano M.I., Belli G., Iannelli A., et al. Evidence for a recessive inheritance of Turcot's syndrome caused by compound heterozygous mutations within the PMS2 gene. Oncogene 19 (2000) 1719-1723
27. Vilkki S., Tsao J.L., Loukola A., Poyhonen M., Vierimaa O., Herva R., et al. Extensive somatic microsatellite mutations in normal human tissue. Cancer Res. 61 (2001) 4541-4544
28. Whiteside D., McLeod R., Graham G., Steckley J.L., Booth K., Somerville M.J., et al. A homozygous germ-line mutation in the human MSH2 gene predisposes to hematological malignancy and multiple cafe-au-lait spots. Cancer Res. 62 (2002) 359-362
29. Bougeard G., Charbonnier F., Moerman A., Martin C., Ruchoux M.M., Drouot N., et al. Early onset brain tumor and lymphoma in MSH2-deficient children. Am. J. Hum. Genet. 72 (2003) 213-216
30. Gallinger S., Aronson M., Shayan K., Ratcliffe E.M., Gerstle J.T., Parkin P.C., et al. Gastrointestinal cancers and neurofibromatosis type 1 features in children with a germline homozygous MLH1 mutation. Gastroenterology 126 (2004) 576-585
31. Menko F.H., Kaspers G.L., Meijer G.A., Claes K., van Hagen J.M., and Gille J.J. A homozygous MSH6 mutation in a child with cafe-au-lait spots, oligodendroglioma and rectal cancer. Fam. Cancer 3 (2004) 123-127
32. Trimbath J.D., Petersen G.M., Erdman S.H., Ferre M., Luce M.C., and Giardiello F.M. Cafe-au-lait spots and early onset colorectal neoplasia: a variant of HNPCC?. Fam. Cancer 1 (2001) 101-105
33. Hegde M.R., Chong B., Blazo M.E., Chin L.H., Ward P.A., Chintagumpala M.M., et al. A homozygous mutation in MSH6 causes Turcot syndrome. Clin. Cancer Res. 11 (2005) 4689-4693
34. Muller A., Schackert H.K., Lange B., Ruschoff J., Fuzesi L., Willert J., et al. A novel MSH2 germline mutation in homozygous state in two brothers with colorectal cancers diagnosed at the age of 11 and 12 years. Am. J. Med. Genet. A (2005)
35. Ostergaard J.R., Sunde L., and Okkels H. Neurofibromatosis von Recklinghausen type I phenotype and early onset of cancers in siblings compound heterozygous for mutations in MSH6. Am. J. Med. Genet. A 139 (2005) 96-105
36. Rodriguez-Bigas M.A., Boland C.R., Hamilton S.R., Henson D.E., Jass J.R., Khan P.M., et al. A National Cancer Institute Workshop on Hereditary Nonpolyposis Colorectal Cancer Syndrome: meeting highlights and Bethesda guidelines. J. Natl. Cancer Inst. 89 (1997) 1758-1762
37. Schouten J.P., McElgunn C.J., Waaijer R., Zwijnenburg D., Diepvens F., and Pals G. Relative quantification of 40 nucleic acid sequences by multiplex ligation-dependent probe amplification. Nucleic Acids Res. 30 (2002) e57
38. Bunyan D.J., Eccles D.M., Sillibourne J., Wilkins E., Thomas N.S., Shea-Simonds J., et al. Dosage analysis of cancer predisposition genes by multiplex ligation-dependent probe amplification. Br. J. Cancer 91 (2004) 1155-1159
39. Baudhuin L.M., Ferber M.J., Winters J.L., Steenblock K.J., Swanson R.L., French A.J., et al. Characterization of hMLH1 and hMSH2 gene dosage alterations in Lynch syndrome patients. Gastroenterology 129 (2005) 846-854
40. Lynch H.T., Coronel S.M., Okimoto R., Hampel H., Sweet K., Lynch J.F., et al. A founder mutation of the MSH2 gene and hereditary nonpolyposis colorectal cancer in the United States. JAMA 291 (2004) 718-724
41. Wang Y., Friedl W., Sengteller M., Jungck M., Filges I., Propping P., et al. A modified multiplex PCR assay for detection of large deletions in MSH2 and MLH1. Hum. Mutat. 19 (2002) 279-286